3544 results for «2103»

Filter By

3544 results

RADIANCE-HTN SOLO: six-month results of renal denervation in patients on medications using the ReCor Paradise endovascular ultrasound system in a randomised, blinded, sham-controlled study

23 May 2019 – From EuroPCR 2019

Consult this session to learn all about the latest results from the RADIANCE-HTN SOLO cohort at the 6-month time point to assess efficacy of renal denervation in patients after medication titration.

RADIANCE-HTN SOLO: six-month results of renal denervation in patients on medications using the ReCor Paradise endovascular ultrasound system

Precision meets simplicity – Complex PCI guided by a 2nd generation fibre optic physiology guidewire

23 May 2019 – From EuroPCR 2019

Consult this session to learn through various compelling clinical cases how the new OptoWire physiology guidewire can make the difference compared to the current pressurewires, and how to use it in bifurcations, serial lesions and CAD and aortic stenoses.

Precision meets simplicity – Complex PCI guided by a 2nd generation fibre optic physiology guidewire

Latest developments in cerebral embolic protection

23 May 2019 – From EuroPCR 2019

Consult this session to hear the latest update on the US REFLECT phase II trial, to learn about the EU experience with the TriGUARD 3 CEP device and to learn about Keystone Heart's EU roadmap.

Latest developments in cerebral embolic protection

Update on management of complex calcified coronary lesions

23 May 2019 – From EuroPCR 2019

Consult this session to discover updates on the management of complex calcified coronary lesions, to better understand which cases may be almost impossible to stent, to learn techniques to make stenting possible, and more!

Update on management of complex calcified coronary lesions

Emerging transcatheter-based interventions for volume management in advanced heart failure

23 May 2019 – From EuroPCR 2019

Consult this session to learn more about emerging device-based approach in heart failure with preserved ejection fraction, the devices specifics and how to use them, and more!

Emerging transcatheter-based interventions for volume management in advanced heart failure

Complex PCI in high bleeding risk patients

23 May 2019 – From EuroPCR 2019

Consult this session to learn more about how to identify high bleeding risk (HBR) patients requiring adjusted antithrombotic strategy and how to tailor PCI strategies to specific HBR patient for drug-device synergy.

Complex PCI in high bleeding

What's new in hypertension treatment – An update for interventionists

23 May 2019 – From EuroPCR 2019

Consult this session to discover the updates in hypertension treatment: learn about new devices for hypertension management, how to apply the new hypertension guidelines in clinical practice, and more!

What's new in hypertension treatment – An update for interventionists

Complex aortoiliac bifurcation treatment - LIVE Case

23 May 2019 – From EuroPCR 2019

Consult this session to learn more about how to select the best vascular access option (single versus multiple) and how to drive your device choice for patient-/lesion-individualised treatment.

LIVE demonstration from Clinique Pasteur - Toulouse, France

Complex aortoiliac bifurcation

Exploring evidence and experience with magnesium scaffold Magmaris

23 May 2019 – From EuroPCR 2019

Consult this session on magnesium scaffold Magmaris to learn more about the available data on its clinical use and to review interesting intravascular imaging data after Magmaris implantation.

Exploring evidence and experience with magnesium scaffold Magmaris

Innovations in complex multivessel disease PCI – SYNTAX II strategy and beyond

23 May 2019 – From EuroPCR 2019

Consult this session on innovations in complex multivessel disease PCI to learn more about the recent innovations in physiology and IVUS guidance and to review current data on rotational atherectomy for calcified lesion preparation.

Innovations in complex multivessel disease PCI – SYNTAX II strategy and beyond

Controversies and future perspectives of antithrombotic therapy in atrial fibrillation patients undergoing coronary and valvular transcatheter interventions

23 May 2019 – From EuroPCR 2019

Consult this session to learn about the updated perspective on the bleeding definition in interventional cardiology, and antithrombotic treatment regimens in atrial fibrillation patients undergoing PCI or TAVI.

Controversies and future perspectives of antithrombotic therapy in atrial fibrillation patients undergoing coronary and valvular transcatheter interventions

Physiology or intracoronary imaging; or both? or none? - part 2

27 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on physiology and intracoronary imaging presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: SOCT-PCI Study, impact of PPG index on PCI, angiography-derived IMR.

Physiology or intracoronary imaging; or both? or none?

Two-year outcomes of Tendyne Transcatheter Mitral Valve Implementation (TMVI) to treat symptomatic severe mitral regurgitation

Learn more about the 2-year outcomes of the first 100 patients treated as part of the Tendyne Expanded Clinical Study, and how the latest Tendyne clinical evidence may change the way the heart team treats mitral regurgitation.

Videos included on this page: the Hot Line presentation and...

Two-year outcomes of

Shaping care pathways for severe aortic stenosis patients in a COVID-19 context

Watch this roundtable discussion on the management of aortic stenosis in the context of the COVID-19 pandemic and how to readdress the treatment options and pathways to serve the needs of the patients in this difficult global crisis.

Shaping care pathways for severe aortic stenosis patients in a COVID-19 context

Portico FlexNav - Optimise TAVI outcomes from routine to complex cases

Watch this session if you want to learn how Portico enables you to achieve favorable haemodynamics and patient outcomes, to learn about the new Portico with FlexNav TAVI system and its deliverability and to learn the importance of looking ahead during transcatheter aortic valve implantation and...

Portico FlexNav - Optimise TAVI outcomes from routine to complex cases

Hot line on PCI: high bleeding risk and DAPT - part 2

27 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on high bleeding risk and DAPT presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: TWILIGHT CHINA, SMART-CHOICE, LEADERS FREE III.

Hot lines on PCI: high bleeding risk and DAPT

Hot lines on Mitral interventions – part 1

25 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on mitral interventions presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: EVOQUE replacement, Tendyne TMVI, CLASP, V-i-V and V-i-R, Tendyne MAC.

Hot Lines on mitral interventions

PCR e-Course Hot lines on TAVI – part 1

25 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on TAVI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: Evolut Low-Risk trial, MyVal-1 study, BASILICA vs. control, non-invasive ultrasound therapy, long-term outcomes after V-i-V.

Hotlines on TAVI

Crossover results from the RADIANCE-HTN SOLO trial

26 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to learn about latest results from RADIANCE-HTN SOLO cohort and to review blood pressure results following crossover to ultrasound RDN in patients originally randomised to the sham arm in RADIANCE-HTN SOLO.

Videos included on this page: the Hot Line presentation, an...

Latest evidence from the RADIANCE-HTN trial and the path to clinical adoption

Paclitaxel DCB for coronary lesions: 12-month results. Do drug-coated balloons PREVAIL?

25 Jun 2020 – From PCR e-Course 2020

Consult this abstract to discover the PREVAIL trial results and the implications for drug-coated balloons in percutaneous coronary intervention.

Videos included on this page: the abstract presentation and an Investigator Perspective.

Paclitaxel DEB for coronary lesions: 12-month results of the PREVAIL study
Didn’t find what you were looking for?